ORAMED PHARMACEUTICALS INC (ORMP)

US68403P2039 - Common Stock

2.92  +0.1 (+3.55%)

After market: 3.01 +0.09 (+3.08%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-8-31)
2020
(2020-8-31)
2019
(2019-8-31)
Revenue
1.34M2.70M2.70M2.71M2.70M
Minority Interest Expense
437.00K1.20M750.00KN/AN/A
Cost Of Goods
N/AN/AN/A0.0090.00K
Gross Profit
N/AN/A904.00K2.71M2.61M
Operating Expenses
17.11M43.30M26.93M14.47M17.24M
Research and Development
8.97M27.64M20.99M10.24M13.52M
Selling, General, and Administrative Expenses
8.43M15.66M5.94M4.23M3.72M
Operating Income
-15.77M-40.60M-24.22M-11.76M-14.63M
Interest Income/Expense
22.26M2.77M1.24M260.00K630.00K
Other Income/Expense
-1.40M170.00K-10.00K-10.00K-50.00K
Income Before Taxes
5.09M-37.66M-22.99M-11.51M-14.06M
Income Tax
0.00100.00K0.000.00300.00K
Net Income
5.53M-36.56M-22.24M-11.51M-14.36M
EBITDA
-15.57M-40.54M-24.14M-11.75M-14.62M
 
Per Share Data
EPS Diluted Total Ops
0.14-0.94-0.78-0.56-0.82
Non GAAP EPS
0.14-0.94-0.78-0.58-0.82
 
Statistics
Gross Profit Margin
N/AN/A33.48%100.00%96.67%
Profit Margin
412.31%-1354.07%-823.70%-424.72%-531.85%
Operating Profit Margin
-1176.79%-1503.70%-897.04%-433.95%-541.85%

All data in USD

Charts